Literature DB >> 23105963

Effects of Aerobic Fitness and Adiposity on Coagulation Biomarkers in Men vs. Women with Elevated Blood Pressure.

Kathleen L Wilson1, Lianne Tomfohr, Kate Edwards, Cindy Knott, Suzi Hong, Laura Redwine, Karen Calfas, Cheryl L Rock, Roland von Känel, Paul J Mills.   

Abstract

A hypercoagulable state is a potential mechanism linking elevated blood pressure (BP), adiposity and a sedentary lifestyle to development of coronary heart disease (CHD). We examined relationships among aerobic fitness and adiposity in 76 sedentary subjects with elevated BP. Blood levels of plasminogen activator inhibitor-1 (PAI-1), D-dimer, von Willebrand factor (vWF) and thrombomodulin were assessed as biomarkers of coagulation. In individuals with elevated BP, percent body fat and fitness were associated with biomarkers indicative of a hypercoagulable state, even after demographic and metabolic factors were considered. D-dimer was positively associated with percent body fat (beta=0.37, p=0.003). PAI-1 was higher in men than in women (beta=-0.31, p=0.015) and associated with lower VO2peak (beta=-0.35, p=0.024). Thrombomodulin was positively associated with VO2peak (beta=0.56, p< 0.01). vWF was not significantly associated with fitness or adiposity. Our results emphasise that both percent body fat and physical fitness are important in the maintenance of haemostatic balance.

Entities:  

Year:  2012        PMID: 23105963      PMCID: PMC3480183     

Source DB:  PubMed          Journal:  Eur J Cardiovasc Med        ISSN: 2042-4884


  40 in total

1.  Relationship between visceral fat and PAI-1 in overweight men and women before and after weight loss.

Authors:  M Kockx; R Leenen; J Seidell; H M Princen; T Kooistra
Journal:  Thromb Haemost       Date:  1999-11       Impact factor: 5.249

2.  Human gender differences in fibrinolytic responses to exercise training and their determinants.

Authors:  Onanong Kulaputana; Richard F Macko; Ioana Ghiu; Dana A Phares; Andrew P Goldberg; James M Hagberg
Journal:  Exp Physiol       Date:  2005-08-23       Impact factor: 2.969

3.  Plasma immunoreactive endothelin, but not thrombomodulin, is increased in patients with essential hypertension and ischemic heart disease.

Authors:  M Naruse; M Kawana; S Hifumi; K Naruse; I Yoshihara; T Oka; Y Kato; C Monzen; F Kurimoto; K Ohsumi
Journal:  J Cardiovasc Pharmacol       Date:  1991       Impact factor: 3.105

4.  Hemostatic, metabolic, and androgenic risk factors for coronary heart disease in physically active and less active postmenopausal women.

Authors:  E T Stevenson; K P Davy; D R Seals
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-05       Impact factor: 8.311

5.  Management of obesity in adults: European clinical practice guidelines.

Authors:  Constantine Tsigos; Vojtech Hainer; Arnaud Basdevant; Nick Finer; Martin Fried; Elisabeth Mathus-Vliegen; Dragan Micic; Maximo Maislos; Gabriela Roman; Yves Schutz; Hermann Toplak; Barbara Zahorska-Markiewicz
Journal:  Obes Facts       Date:  2008-04-18       Impact factor: 3.942

6.  Physical fitness and incidence of hypertension in healthy normotensive men and women.

Authors:  S N Blair; N N Goodyear; L W Gibbons; K H Cooper
Journal:  JAMA       Date:  1984-07-27       Impact factor: 56.272

Review 7.  On the role of coagulation and fibrinolysis in atherosclerosis.

Authors:  I Juhan-Vague; D Collen
Journal:  Ann Epidemiol       Date:  1992-07       Impact factor: 3.797

8.  Cardiorespiratory fitness influences the blood pressure response to experimental weight gain.

Authors:  Christopher L Gentile; Jeb S Orr; Brenda M Davy; Kevin P Davy
Journal:  Obesity (Silver Spring)       Date:  2007-12       Impact factor: 5.002

Review 9.  The potential anti-inflammatory benefits of improving physical fitness in hypertension.

Authors:  Kate M Edwards; Michael G Ziegler; Paul J Mills
Journal:  J Hypertens       Date:  2007-08       Impact factor: 4.844

10.  Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy.

Authors:  I-Min Lee; Eric J Shiroma; Felipe Lobelo; Pekka Puska; Steven N Blair; Peter T Katzmarzyk
Journal:  Lancet       Date:  2012-07-21       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.